Endocrinology Advisor interviewed experts to explore mechanisms, clinical implications, and research needs pertaining to the diabetes-dementia link.
More than half of the new approvals of Breakthrough Therapy drugs were based on a single pivotal trial.
While it is now well-established that having MS should not limit patients’ reproductive choices, this was not always the case.
According to a 2016 study, the mean price of insulin increased nearly 3-fold between 2002 and 2013.
Findings suggest that insulin resistance and deficiency may increase the risk of Alzheimer disease via their influence on brain function.
Current oral contraceptive products contain lower doses of estrogen than those used in the past, prompting reconsideration of risks and benefits.
Insulin resistance contributes to the increased risk of type 2 diabetes in individuals with polycystic ovary syndrome.